Anuh Pharma Limited (BOM:506260)
80.72
+1.59 (2.01%)
At close: Jul 27, 2026
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 8.09 billion as of July 28, 2026. Its market cap has decreased by -18.51% in one year.
Market Cap
8.09B
Enterprise Value
7.56B
Revenue
7.72B
Ranking
n/a
PE Ratio
19.71
Stock Price
80.72
ChartMarket Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 8.09B, an increase of 3,586.58%. That is a compound annual growth rate of 21.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 8.09B | 0.30% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermenta Biotech | 12.73B |
| Syncom Formulations (India) | 12.40B |
| Lincoln Pharmaceuticals | 11.63B |
| Wanbury | 11.56B |
| Bharat Parenterals | 10.55B |
| Sudarshan Pharma Industries | 9.97B |
| Kopran | 9.75B |
| Hexagon Nutrition | 7.89B |